Business profile
Loading canonical business information.
About
Services
Products
Articles & research
Offers
Published by the business. Confirm current availability and terms with the business.
Browse productsPromotions
Published by the business. Confirm current availability and terms with the business.
Browse productsFrequently asked questions
Answers published by the business.
Published agent capabilities
Capabilities recorded in this listing. Their presence is not a live availability check.
AI-readable discovery
Read the structured business information and inspect the published discovery documents.
Machine-readable documents do not by themselves establish a live AI agent, checkout or business ownership.
Request a quote
Loading quote availability…
Sources
Report this listing
Tell us what needs reviewing. Removal requests are reviewed before any change is made.
Request removalProfile information
Publication, owner access and business registry verification are separate. Verification badges describe the checks completed; public references identify this listing.
Structured public business summary
Numedicus
Numedicus – Focussed on secondary uses for existing drugs Skip to content Home About Strategy Portfolio Blog Contact world class drug repurposing Based in Cambridge, England. More Visit our repurposing database Numedicus is the owner of the DrugRepurposing Online database, which features over 4,000 potential new uses for existing compounds, containing both existing and abandoned drugs and focussed on functional, experimentally validated content. More Track record Numedicus has identified a number of clinical-stage drug repurposing projects, supported by method-of-use patents more Methods and output There are various different methods of identifying drug repurposing projects more Types of switch Therapeutic Switch, or drug repurposing projects, come in various different flavours more Types of collaborator Numedicus uses therapeutic switching to identify secondary uses for existing drugs in practically all areas more David Cavalla has 35 years experience in various senior scientific and commercial roles within the pharmaceutical industry.
United Kingdom
Business nature
- Primary business nature
- Not provided
- Customer market
- Not provided
Operating hours
Hours not provided.
Categories
- Software & IT (primary)
Service areas
- United Kingdom
Public contacts
- facebook: https://www.facebook.com/sharer.php?u=https://www.numedicus.co.uk/2014/05/27/value-and-cost-based-pricing/
- linkedin: https://www.linkedin.com/shareArticle?mini=true&url=https://www.numedicus.co.uk/2014/05/27/value-and-cost-based-pricing/&title=Value%20and%20cost-based%20pricing
- twitter: https://twitter.com/share?url=https://www.numedicus.co.uk/2014/05/27/value-and-cost-based-pricing/
Declared AI capabilities
- Online booking — Detected from public website navigation or discovery metadata.
- Online support — Detected from public website navigation or discovery metadata.
Directory status
Registry verification: Not Registry Verified
Directory score: 85
Public source evidence
- Numedicus – Focussed on secondary uses for existing drugs
- Value and cost-based pricing – Numedicus
- Pricing – Numedicus
- pricing – Numedicus
- Numedicus
- Contact – Numedicus
- About – Numedicus
- Types of switch – Numedicus
- Track record – Numedicus
- Strategy – Numedicus
- Cachexia development enters new phase – Numedicus
- Contact – Numedicus
- About – Numedicus
- Value and cost-based pricing – Numedicus